Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pancreatic Cancer, Neoadjuvant Therapy

Sam Yip

MD, PhD, FRCSC

🏢BC Cancer Agency🌐Canada

Associate Professor of Surgery

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Sam Yip is a surgical oncologist and translational researcher at BC Cancer specializing in pancreatic cancer. He has investigated neoadjuvant FOLFIRINOX for borderline resectable pancreatic ductal adenocarcinoma and studied ctDNA correlates of response to preoperative therapy. His work examines how genomic analysis of pretreatment biopsies can inform neoadjuvant regimen selection and predict surgical outcomes.

Share:

🧪Research Fields 研究领域

resectable pancreatic cancer neoadjuvant
borderline resectable pancreas
FOLFIRINOX neoadjuvant pancreas
gemcitabine nab-paclitaxel perioperative
R0 resection rates neoadjuvant

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Sam Yip 的研究动态

Follow Sam Yip's research updates

留下邮箱,当我们发布与 Sam Yip(BC Cancer Agency)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment